Wellnex Life (ASX:WNX) managing director Zack Bozinovski admits that local investors don’t fully understand the power and ...

This Fool considers how two low-risk and well-established FTSE shares could offer stability and growth during a period of ...

Advancements in non-opioid therapies, AI-integrated solutions, and regenerative medicine drive transformative growth in the pain management market. AUSTIN, TX, UNITED STATES, January 21, 2025 ...

Both assets are poised to enter registrational studies under accelerated approval pathways, according to Jefferies. GSK to Stay Out of Obesity—but not GLP-1s At JPM25 on Monday, GSK Chief Scientific ...

Haleon was established in 2022 as a corporate spin-off from GSK. The sale of 700 million Haleon shares at 357 pence apiece is a discount of about 2.8% to the stock's closing price on Tuesday, Reuters ...

Depemokimab data reveals 72% reduction in hospitalizations; projected sales hit £4 billion. GSK plc GSK expects strong momentum in the specialty business segment to continue with growth from ...

Shares in the maker of Sensodyne, Panadol and Advil ... which was created by the merger of GSK and Pfizer's consumer healthcare businesses in 2019. It was spun off from the British drugmaker ...

Panadol and Advil painkillers, and Centrum vitamins. Pfizer is a New York-based pharmaceutical and biotechnology firm. Haleon was formed in 2019 as a joint venture of Pfizer and GSK PLC's consumer ...

Panadol and Advil painkillers, and Centrum vitamins. Pfizer is a New York-based pharmaceutical and biotechnology firm. Haleon was formed in 2019 as a joint venture of Pfizer and GSK PLC's consumer ...

Haleon--which owns brands such as Sensodyne toothpaste, Aquafresh mouthwash and over-the-counter medicines Panadol and Advil--was formed in July 2019 through the merger of GSK and Pfizer's ...

Following GSK’s deal-heavy end to 2024, Chief Scientific Officer Tony Wood, Ph.D., doesn’t expect the trend to let up in the new year, zeroing in on partnerships that can expand knowledge ...